Osteoclastic activity in the bone marrow triggered by tumor cells is supposed to result in the release of TGF-β from the bone matrix, which then stimulates cancer cells to release osteolytic cytokines, further promoting bone metastases in BC [7, 9]. This evidence concerns the gene TGFB1 and breast cancer.